PLAY PODCASTS
Episode 30: ProMIS Neurosciences Chairman and CEO Eugene Williams on Developing Treatments for Alzheimer’s
Season 2022 · Episode 30

Episode 30: ProMIS Neurosciences Chairman and CEO Eugene Williams on Developing Treatments for Alzheimer’s

ProMIS Neurosciences Inc. (NASDAQ: PMN | TSX: PMN) Chairman and CEO Eugene Williams talks to Glob...

Stocks To Watch · Global One Media Pte. Ltd.

August 19, 202211m 11s

Audio is streamed directly from the publisher (pdcn.co) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

ProMIS Neurosciences Inc. (NASDAQ: PMN | TSX: PMN) Chairman and CEO Eugene Williams talks to Global One Media to share the science behind targeting misfolded proteins to develop treatments for Alzheimer's disease, amyotrophic lateral sclerosis, multiple system atrophy, and other neurologic disorders. Williams also shares their exciting collaborations and partnerships to further advance the treatments in the life science sector.